Table 5.
Evidence overview of Aquablation versus TURP
| Outcome | Number of trials (evaluated) | Intervention | Control | Absolute risk difference (95% CI) | Relative risk (95% CI) | Quality of evidence |
|---|---|---|---|---|---|---|
| % (n/N) or Mean change | % (n/N) or mean change | |||||
| Responders, based on IPSS reduction of ≥50% | No data long term | |||||
| IPSS, mean change from baseline: long-term follow-up (>12 mo) | No data long term | |||||
| IPSS-QoL, mean change from baseline: long-term follow-up (>12 mo) | No data long term | |||||
| Need for reoperation | 1 (181) | 3 (3/116) | 2 (1/65) | 1.0% (–3.1 to 5.2) | 1.7 (0.2–15.8) | Very lowa |
| Transfusion | 1 (181) | 1 (1/116) | 0 (0/65) | 0.9% (–2.1 to 3.8) | 1.7 (0.07–41.0) | Very lowa |
| Urinary incontinence | NR, but no differences in combined urinary urgency, frequency, difficulty, or leakage | |||||
CI = confidence intervals; IPSS = International Prostate Symptom Score; NR = not reported; QoL = quality of life; TURP = transurethral resection of the prostate.
Downgraded based on the following:
a
Very wide confidence interval and few events.